Armed Forces Transgender Dependent Protection Act This bill expands the policy of the Office of Special Needs within the Department of Defense to address transgender dependents. Specifically, the bill codifies the definition of a medical or educational special need to include gender dysphoria. Under the bill, the policy of the office must prohibit the assignment of a military family with special needs to a permanent duty location where the law restricts medically necessary treatment for a medical or educational special need. A member who is serving at a location when such a law is established may elect to be reassigned.
Vaccine Access Improvement Act of 2021 This bill modifies the excise tax on certain vaccines to (1) automatically impose the tax on vaccines that the Department of Health and Human Services (HHS) adds to the Vaccine Injury Table, and (2) require HHS to notify the Department of the Treasury and Congress when new vaccines are added to the table. (The excise tax funds the National Vaccine Injury Program, which compensates people who have been injured by vaccines listed on the table.)
Improving Access to Medicare Coverage Act of 2021 This bill deems an individual receiving outpatient observation services in a hospital as an inpatient for purposes of satisfying the three-day inpatient hospital-stay requirement with respect to Medicare coverage of skilled nursing facility services.
Made in America Emergency Preparedness Act This bill establishes in the legislative branch the National Commission on United States Preparedness for National Emergencies and requires any medical, pharmaceutical, or emergency preparedness product deemed integral to a response to a national emergency to be manufactured and procured in the United States beginning on and after January 1, 2026. The commission must, among other things, examine and report on the COVID-19 pandemic in the United States in 2020 and the private sector response, investigate the origin of the COVID-19 virus and measures for mitigating the impacts of future physical and medical national disasters, determine what medical, pharmaceutical, and emergency preparedness products are deemed to be essential to emergency preparedness, and report on infrastructure or capability deficiencies in hospitals and medical centers. States must implement the commission's findings or lose access to federal emergency preparedness funds. The bill allows 100% tax expensing for qualified pharmaceutical and medical device manufacturing property (e.g., personal protective equipment) placed in service after 2020 and before 2027.
Clean Water Standards for PFAS Act of 2021 This bill directs the Environmental Protection Agency (EPA) to develop requirements and incentives to limit the discharge of perfluoroalkyl and polyfluoroalkyl substances (PFAS) into certain waters of the United States. PFAS are man-made and may have adverse human health effects. A variety of products contain the compounds, such as nonstick cookware or weatherproof clothing. Within two years, the EPA must publish water quality criteria for each measurable perfluoroalkyl substance, polyfluoroalkyl substance, and class of PFAS. The water quality criteria must determine how much of these substances can be present in water before it is likely to harm human health. Within four years, the EPA must publish a final rule that establishes, for each priority industry category specified in the bill, effluent limitations guidelines and standards for the discharge of each measurable perfluoroalkyl substance, polyfluoroalkyl substance, and class of PFAS. Under the Clean Water Act, effluent limitations restrict the quantities, rates, and concentrations of chemical, physical, biological, and other constituents which are discharged from point sources (e.g., a discernible source such as a pipe) into navigable waters, the ocean, or other specified waters. In addition, the EPA must award grants to owners and operators of publicly owned treatment works for implementing the effluent limitations guidelines and standards.
Buy Green Act of 2021 This bill provides for federal procurement of clean energy products. Specifically, the bill establishes a Clean Energy Fund at the Department of Energy (DOE) and authorizes DOE to transfer amounts from the fund to federal agencies for clean energy-related purchases. The bill creates a grant program for state, local, and tribal governments to make such purchases. The bill (1) provides grants to electrify the federal vehicle fleet, to states and municipalities to electrify public transit and school buses, and to design, build, and retrofit buildings to be more energy efficient; and (2) establishes a grant program for U.S. companies to invest in clean energy manufacturing by retrofitting or building facilities that produce clean energy products. The bill (1) establishes specified labor protections applicable to projects funded by grants in this bill and for manufacturers of specified products; and (2) directs 40% of state, local, and tribal grant funding for grants provided by this bill to purchases that benefit frontline, disadvantaged, and vulnerable communities that have been environmentally neglected. The bill establishes within DOE a Green Procurement Oversight Advisory Board. The Government Accountability Office shall conduct oversight of the use of funds and publicly report on program efficacy each year.
Surface Transportation Research and Development Act of 202 1 This bill addresses provisions related to surface transportation research, development, and deployment programs of the Department of Transportation (DOT). Among other provisions, the bill reauthorizes through FY2026 DOT highway research and development programs, including highway safety, technology and innovation deployment, training and education, and intelligent transportation systems; sets forth a program to provide awards to institutions of higher education or nonprofit research organizations to establish regional road weather research and development centers; reauthorizes through FY2026 the University Transportation Centers Program, the Bureau of Transportation Statistics, the public transportation research and development program, the National Cooperative Rail Research Program, the hazardous materials research and development program, and the National Cooperative Freight Transportation Research Program; establishes Centers of Excellence to advance research and development that improves the resilience of regions of the United States to natural disasters, extreme weather, and the effects of climate change on modal and multimodal transportation and infrastructure; directs DOT to carry out and publish the results of a study for the purpose of informing land use and transportation planning for accessible health, food, education, and other essential services and activities; and requires DOT to establish a multimodal national cooperative freight transportation research program, a Heavy Freight Automated Trucking Research Initiative, and an Advanced Transportation Research and Innovation Program.
This resolution expresses support for the designation of Stroke Awareness Month.
Algorithmic Justice and Online Platform Transparency Act This bill establishes requirements for certain commercial online platforms (e.g., social media sites) that withhold or promote content through algorithms and related computational processes that use personal information. The platforms must make disclosures about their collection and use of personal information and their content moderation practices; retain specified records that describe how the algorithms use personal information and assess whether the algorithms produce disparate outcomes based on race and other demographic factors in terms of access to housing, employment, financial services, and related matters; employ algorithms safely and effectively; and allow users to access and transfer their personal information. If a platform uses algorithms to publish or sell advertising, it must maintain a library of the advertisements. The Federal Trade Commission must also adopt rules concerning deceptive advertising. A platform's chief executive officer or other senior officer must certify compliance with disclosure requirements. Additionally, platforms may not (1) employ algorithms or other design features that result in discrimination or similar harms based on demographic or biometric factors, or (2) process information such that it impairs voting rights. Further, users of a platform may not violate civil rights laws using the platform's algorithms. The bill prohibits waivers or other methods that limit rights under the bill; provides whistleblower protections for individuals who report violations; and authorizes enforcement by specified federal agencies, states, and private individuals. The bill also provides funding for an interagency task force to study the discriminatory use of personal information by platforms' algorithms.
LymeX Authorization Act This bill authorizes the Department of Health and Human Services to carry out prize competitions to accelerate innovation in the prevention, diagnosis, and treatment of Lyme disease. Lyme disease is a bacterial infection carried by ticks that can spread to joints, the heart, and the nervous system.
Organ Donation Clarification Act of 2021 This bill specifies that certain payments and pilot programs relating to organ donation do not violate the National Organ Transplant Act, which prohibits the exchange of valuable consideration for human organs. Specifically, it excludes additional types of reimbursements and payments related to organ donation from the definition of valuable consideration , such as costs for (1) dependent care; (2) certain medical expenses for up to 10 years after a donation; (3) paperwork or legal services; and (4) term life insurance policies, subject to some limitations. In addition, the federal government, states, or local governments may carry out pilot programs to evaluate the effects of removing disincentives or providing noncash benefits on the availability of organs for transplant, provided these programs meet ethical and other conditions.
This bill requires the Environmental Protection Agency (EPA) to amend its regulations to revise the standards for the emission of ethylene oxide. Specifically, regulations must be revised based on results from the National Center for Environmental Assessment report titled Evaluation of the Inhalation Carcinogenicity of Ethylene Oxide . The bill also requires revisions to apply maximum achievable control technology requirements to chamber exhaust vents. Maximum achievable control technology standards are established for sources of hazardous air pollutants to limit or control emissions. Additionally, the revisions must apply to area sources and major sources of ethylene oxide. The EPA must carry out a residual risk assessment with respect to the revised standards. Finally, the EPA must notify the public of violations under the revised standards, and failure to do so will result in an investigation to assess the health risks and prevent a future failure of notification.
